Bryan Reasons

Track

Insider profile

Currently holds positions in Keenova Therapeutics PLC, Recro Pharma Inc and Aclaris Therapeutics Inc

Positions

Position Company Period
Chief Financial Officer, Executive Vice President Keenova Therapeutics PLC March 18, 2019 -
Independent Director Recro Pharma Inc March 3, 2017 -
Independent Director Aclaris Therapeutics Inc April 20, 2018 -
Chief Financial Officer, Senior Vice President - Finance Amneal Pharmaceuticals Inc Dec. 12, 2012 - Jan. 1, 2018
Acting Chief Financial Officer, Vice President - Finance Amneal Pharmaceuticals Inc June 29, 2012 - Dec. 12, 2012
Bryan Reasons's trades of Recro Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
471.65
Quantity 40,424 -46.1%
Value US$678,213
Transaction date
Sale
Price
115.22
Quantity 23,457 -3.3%
Value US$2,409,199
Transaction date
Purchase
Price
26.23
Quantity 18,995 -3.5%
Value US$649,038
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-28 2023-08-28
B Purchase
40,424 -46.1%
471.65
US$678,213 		40,424 -46.1% 471.65 US$678,213
2020-12-07 2020-12-03
S Sale
23,457 -3.3%
115.22
US$2,409,199 		23,457 -3.3% 115.22 US$2,409,199
2019-06-07 2019-06-07
B Purchase
18,995 -3.5%
26.23
US$649,038 		18,995 -3.5% 26.23 US$649,038